• OPEN AN ACCOUNT
Indian Indices
Sensex
76,874.53 -82.74
( -0.11%)
Global Indices
Nasdaq
53,227.35 -353.64
(-0.66%)
Dow Jones
7,711.10 -21.66
(-0.28%)
Hang Seng
66,147.06 -258.50
(-0.39%)
Nikkei 225
10,824.26 31.76
(0.29%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
42.89
1059.91
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.06
 

Raw Edge Industrial Solutions reports standalone net profit of Rs 0.20 crore in the March 2026 quarter
May 22,2026
Net profit of Raw Edge Industrial Solutions reported to Rs 0.20 crore in the quarter ended March 2026 as against net loss of Rs 0.91 crore during the previous quarter ended March 2025. Sales declined 0.75% to Rs 10.61 crore in the quarter ended March 2026 as against Rs 10.69 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.13 crore in the year ended March 2026 as against net loss of Rs 1.04 crore during the previous year ended March 2025. Sales declined 20.08% to Rs 35.79 crore in the year ended March 2026 as against Rs 44.78 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales10.6110.69 -1 35.7944.78 -20
OPM %6.606.55 -7.186.81 -
PBDT0.390.36 8 1.201.43 -16
PBT0.26-0.09 LP -0.64-0.35 -83
NP0.20-0.91 LP -0.13-1.04 88